Cemtrex ROCE
What is the ROCE of Cemtrex?
The ROCE of Cemtrex Inc. is -41.98%
What is the definition of ROCE?
Return on capital employed (ROCE) is a financial ratio that measures a company’s profitability and the efficiency with which its capital is used.
= EBIT / (assets - current liabilities)
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE of companies in the Industrials sector on NASDAQ compared to Cemtrex
What does Cemtrex do?
cemtrex, inc. (nasdaq:cetx) is a diversified technology company that's driving innovation in a wide range of sectors, including smart technology, virtual and augmented realities, advanced electronic systems, industrial solutions, and intelligent security systems.
Companies with roce similar to Cemtrex
- Apogee Minerals Ltd has ROCE of -42.19%
- Foresight Autonomous Ltd has ROCE of -42.15%
- Conscience Capital has ROCE of -42.15%
- Tonix Pharmaceuticals has ROCE of -42.12%
- Xau Resources Inc has ROCE of -42.12%
- Ameri Inc has ROCE of -42.09%
- Cemtrex has ROCE of -41.98%
- Arcutis Biotherapeutics Inc has ROCE of -41.97%
- MediWound Ltd has ROCE of -41.91%
- Solid Biosciences Inc has ROCE of -41.85%
- Bionano Genomics has ROCE of -41.85%
- Mereo BioPharma plc has ROCE of -41.84%
- Fairfax Africa has ROCE of -41.81%